Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 8, 2012 - Issue 1
Submit an article Journal homepage
1,128
Views
15
CrossRef citations to date
0
Altmetric
Editorial

Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack

David S Pisetsky Medical Research Service, 151G Durham Veterans Administration Medical Center, 508 Fulton Street, Durham, NC 27705, USA and Duke University Medical Center, Department of Medicine, Durham, NC 27705, USA. [email protected]
,
Jaewoo Lee Duke Translational Research Institute and Duke University Medical Center, Department of Surgery, Durham, NC 27710, USA
,
Kam W Leong Duke University Medical Center, Departments of Surgery and Biomedical Engineering, Durham, NC 27710, USA
&
Bruce A Sullenger Duke Translational Research Institute and Duke University Medical Center, Department of Surgery, Durham, NC 27710, USA
Pages 1-3 | Published online: 10 Jan 2014

References

  • Lee J, Sohn JW, Zhang Y, Leong KW, Pisetsky D, Sullenger BA. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl Acad. Sci. USA108(34), 14055–14060 (2011).
  • Kono H, Rock KL. How dying cells alert the immune system to danger. Nat. Rev. Immunol.8, 279–288 (2008).
  • Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol.10, 826–837 (2010).
  • Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell140, 805–820 (2010).
  • Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol.28(10), 429–436 (2007).
  • Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res. Ther.10(5), 218 (2008).
  • Kawasaki T, Kawai T, Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol. Rev.243, 61–73 (2011).
  • Takaoka A, Wang Z, Choi MK et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature448, 501–506 (2007).
  • Vallin H, Perers A, Alm GV, Rönnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-α inducer in systemic lupus erythematosus. J. Immunol.163, 6306–6313 (1999).
  • Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med.199(12), 1631–1640 (2004).
  • Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature449, 564–571 (2007).
  • Tian J, Avalos AM, Mao SY et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol.8(5), 487–497 (2007).
  • Urbonaviciute V, Fürnrohr BG, Meister S et al. Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med.205(13), 3007–3018 (2008).
  • Hreggvidsdottir HS, Ostberg T, Wähämaa H et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol.86(3), 655–662 (2009).
  • Pisetsky D. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP–PAMP complexes. Swiss Med Wkly141, 13256–13263 (2011).
  • Prinz M, Garbe F, Schmidt H et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest.116(2), 456–464 (2006).
  • Franklin BS, Ishizaka ST, Lamphier M et al. Therapeutical targeting of nucleic acid-sensing toll-like receptors prevents experimental cerebral malaria. Proc. Natl Acad. Sci. USA108(9), 3689–3694 (2011).
  • Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat. Rev.4, 581–593 (2005).
  • Bartlett DW, Davis ME. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjugate Chem.18, 456–468 (2007).
  • Oney S, Lam RTS, Bompiani KM et al. Development of universal antidotes to control aptamer activity. Nat. Med.15(10), 1224–1229 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.